Related Experiment Video
Updated: May 28, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
ATF3 inhibits PDX-1-stimulated transactivation
Won-Ho Kim1, Min Kyung Jang, Choi Hee Kim
1Division of Metabolic Disease, Department of Biomedical Science, National Institutes of Health, #194 Tongillo, Eunpyung-gu, Seoul 122-701, South Korea.
Endoplasmic reticulum (ER) stress impairs pancreatic beta-cell function by reducing PDX-1 activity. ATF3 protein inhibits PDX-1 activity by blocking p300 coactivation, contributing to type 2 diabetes pathogenesis.
Area of Science:
- Molecular Biology
- Endocrinology
- Cell Biology
Background:
- Chronic endoplasmic reticulum (ER) stress is implicated in pancreatic beta-cell failure and type 2 diabetes.
- Pancreatic and duodenal homeobox-1 (PDX-1) activity is crucial for beta-cell function, and its reduction contributes to diabetes pathogenesis.
- The precise mechanisms by which ER stress diminishes PDX-1 activity remain incompletely understood.
Purpose of the Study:
- To elucidate the role of ATF3 in regulating PDX-1 activity in pancreatic beta-cells under ER stress conditions.
- To investigate how ATF3 modulates PDX-1-mediated gene transactivation and its interaction with coactivators.
Main Methods:
- Reporter gene assays to assess PDX-1 transactivation.
- Co-immunoprecipitation to study protein-protein interactions between ATF3, PDX-1, and p300.
- Chromatin immunoprecipitation to analyze the recruitment of p300 to the insulin promoter.
Main Results:
- ATF3 significantly inhibited PDX-1-stimulated transactivation of reporter plasmids containing PDX-1 binding elements and the glucokinase promoter.
- This inhibition was dependent on the C-terminal domain of ATF3 and involved interaction with PDX-1.
- ATF3 blocked p300-mediated coactivation of PDX-1 and decreased the interaction between p300 and PDX-1.
- ER stress (tunicamycin) and ATF3 overexpression reduced p300 recruitment to PDX-1 on the insulin promoter.
Conclusions:
- ATF3 inhibits PDX-1-mediated transactivation by interfering with p300 coactivation.
- This ATF3-mediated mechanism contributes to ER stress-induced beta-cell dysfunction.
- Understanding this pathway offers potential therapeutic targets for type 2 diabetes.
Related Concept Videos
The JAK-STAT Signaling Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
